# Frank Groenewegen

> Frank Groenewegen is a startup investor at 415 Capital. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [415 Capital](https://shizune.co/investors/profile/415-capital-management)
- Last updated: Aug 2026

Frank Groenewegen is a startup investor at 415 Capital. Frank has over 36 years of investing, management, sales & marketing experience in the MedTech space, the last 28 years as serial investor and entrepreneur. As an investor, he has funded over 40 MedTech companies. As an entrepreneur, he has founded, built, and exited several successful European MedTech distribution companies, including RegisMedical GmbH, Ovum Ventures GmbH (sold to Medtronic in 2009) and Cardiologic GmbH (sold to Boston Scientific in 2002). His companies have commercialized over 20 novel medical device technologies in Europe and helped establish new clinical standards of care, including cerebral embolic protection, transcatheter aortic valve replacement (TAVR), ultrasound renal denervation, and the world’s first pre-mounted coronary stents (Arterial Vascular Engineering). Following Boston Scientific’s acquisition of Cardiologic GmbH, Frank served as the General Manager of Boston Scientific’s Interventional Cardiology Division Germany. Previously, he held several management positions at St. Jude Medical (now part of Abbott), Inc., W. L. Gore & Associates, and AHSC American Hospital Supply Corp. (now part of Baxter).

## About 415 Capital

VC Fund · Oberhaching, Germany

415 CAPITAL is a specialist venture capital firm that invests in early- and development-stage MedTech companies in Europe, the United States and Israel.They primarily invest in innovative medical device technologies addressing cardiovascular disease: the worldwide leading cause of death and the single largest cost driver in the global healthcaresystem.We are investors AND entrepreneurs: As investors, They have funded 45 MedTech companies in the past 28 years. As entrepreneurs, They have founded, built, and exited several successful European MedTech distribution companies.

4 contacts available at 415 Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Azin Parhizgar | Senior Venture Partner | https://shizune.co/investors/profile/azin-parhizgar |
| Frank Groenewegen | Managing Director | https://shizune.co/investors/profile/frank-groenewegen |
| Frederik Groenewegen | Managing Director | https://shizune.co/investors/profile/frederik-groenewegen |
| Ruben Osnabrugge | Partner | https://shizune.co/investors/profile/ruben-osnabrugge-75e5 |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co